Breast Implant RECALL Update
by Pat Battaglia
BIOCELL textured breast implants and tissue expanders, manufactured by Allergan, are just one of many types of implants used in certain breast reconstruction procedures after a mastectomy. They were recalled on July 24, 2019 due to evidence showing this type of implant is linked to an increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). On June 1, 2020, Allergan launched External Link Disclaimer, a campaign to contact patients who may not be aware of the recall.
BIA-ALCL, a rare type of non-Hodgkin’s lymphoma, is most often found in the scar tissue and fluid near the implant. In the majority of cases, surgery is curative, although more widespread disease has occurred in a few. As of January 24, 2020, approximately 307 cases were recognized in the United States. There are 33 known deaths worldwide from the disease.(1)
Most often, the signs of BIA-ALCL are persistent swelling or pain around the implant, but patients should report any changes in the area to their plastic surgeon or another health care provider. Due to the low risk of developing BIA-ALCL, preventive removal of the implant is not recommended.
People who are not aware of the BIOCELL recall or do not know the type of implant they have or their implant history, should:
- Go to www.BIOCELLinformation.com to determine if the company has their implant information.
- Contact their surgeon or hospital where they received implants to determine if the surgeon or hospital has records of their implant information.
